Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$40.84 - $58.14 $1.51 Million - $2.15 Million
-37,000 Reduced 71.71%
14,600 $636,000
Q3 2022

Oct 19, 2022

SELL
$48.37 - $66.5 $338,590 - $465,500
-7,000 Reduced 11.95%
51,600 $2.62 Million
Q1 2022

Apr 26, 2022

SELL
$71.02 - $86.99 $47,583 - $58,283
-670 Reduced 1.13%
58,600 $4.8 Million
Q4 2021

Feb 07, 2022

SELL
$76.72 - $92.68 $843,920 - $1.02 Million
-11,000 Reduced 15.65%
59,270 $5.18 Million
Q1 2021

Apr 27, 2021

SELL
$62.9 - $82.41 $2.92 Million - $3.83 Million
-46,490 Reduced 39.82%
70,270 $5.18 Million
Q4 2020

Jan 22, 2021

SELL
$46.01 - $68.74 $30,826 - $46,055
-670 Reduced 0.57%
116,760 $7.73 Million
Q3 2020

Oct 28, 2020

SELL
$41.91 - $57.81 $167,640 - $231,240
-4,000 Reduced 3.29%
117,430 $5.31 Million
Q2 2020

Jul 16, 2020

BUY
$39.87 - $56.9 $239,219 - $341,400
6,000 Added 5.2%
121,430 $5.84 Million
Q1 2020

Apr 30, 2020

BUY
$34.22 - $76.49 $797,326 - $1.78 Million
23,300 Added 25.29%
115,430 $5.22 Million
Q4 2019

Jan 23, 2020

BUY
$68.92 - $85.27 $6.35 Million - $7.86 Million
92,130 New
92,130 $6.95 Million
Q4 2019

Jan 22, 2020

SELL
$68.92 - $85.27 $6.48 Million - $8.02 Million
-94,030 Closed
0 $0
Q3 2019

Oct 29, 2019

BUY
$71.74 - $86.35 $6.75 Million - $8.12 Million
94,030 New
94,030 $6.94 Million
Q1 2018

Apr 06, 2018

SELL
$79.95 - $89.74 $8.73 Million - $9.8 Million
-109,220 Closed
0 $0
Q4 2017

Jan 10, 2018

SELL
$71.8 - $88.21 $201,040 - $246,987
-2,800 Reduced 2.5%
109,220 $8.73 Million
Q3 2017

Oct 12, 2017

BUY
$60.32 - $70.06 $6.76 Million - $7.85 Million
112,020
112,020 $7.85 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.23B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Waverton Investment Management LTD Portfolio

Follow Waverton Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.